ACM
ELDN icon

ADAR1 Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History

ADAR1 Capital Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3M Sell
974,421
-847,391
-47% -$2M 0.18% 107
2025
Q4 		$2.75M Buy
+1,821,812
New +$4.33M 0.2% 86
2025
Q3 		– Sell
-16,900
Closed -$45.8K – 233
2025
Q2 		$45.8K Buy
16,900
+300
+2% +$900 0.01% 192
2025
Q1 		$56.3K Buy
16,600
+600
+4% +$2.47K 0.01% 179
2024
Q4 		$65.9K Buy
+16,000
New +$63.1K 0.01% 190

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

ADAR1 Capital Management's ELDN Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Eledon Pharmaceuticals (ELDN) stake by 47% in Q1 2026, selling an estimated $2M and leaving 974,421 shares worth $3M. The position accounts for 0.18% of the portfolio, ranked #107.

ADAR1 Capital Management first reported a position in ELDN in Q4 2024 and has held it in 5 quarters since. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • ADAR1 Capital Management held 974,421 shares of Eledon Pharmaceuticals worth $3M as of Q1 2026.
  • ADAR1 Capital Management sold 847,391 Eledon Pharmaceuticals shares in Q1 2026, an estimated $2M.
  • Eledon Pharmaceuticals made up 0.18% of ADAR1 Capital Management's portfolio in Q1 2026, its #107 holding.
  • ADAR1 Capital Management first reported a position in Eledon Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.